Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine infusion as an anesthetic adjuvant in elective abdominal cholecystectomy
IRCT20230830059302N1Phase 4Completed
- Sponsor
- Self Sponsored
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lidocaine in cholelithiasis, sponsored by Self Sponsored. Primary endpoints: Interleukin-6, Interleukin-8 and 2 more. Started Oct 2023; status: completed.
02
Drugs
lidocaine
03
Conditions
cholelithiasis
Beyond the preview
Go deeper on IRCT20230830059302N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230830059302N1.